Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"

Konstantinos C. Siontis; Xiaosong Zhang; Douglas E. Schaubel; Xiaoxi Yao; Peter A. Noseworthy; Nilay D. Shah; Rajiv Saran; Brahmajee K. Nallamothu

doi:10.1161/CIRCULATIONAHA.118.039290

Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"

Konstantinos C. Siontis, Xiaosong Zhang, Douglas E. Schaubel, Xiaoxi Yao, Peter A. Noseworthy, Nilay D. Shah, Rajiv Saran, Brahmajee K. Nallamothu

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1563-1564
Number of pages	2
Journal	Circulation
Volume	139
Issue number	12
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.118.039290
State	Published - Mar 19 2019

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.118.039290

Cite this

Siontis, K. C., Zhang, X., Schaubel, D. E., Yao, X., Noseworthy, P. A., Shah, N. D., Saran, R., & Nallamothu, B. K. (2019). Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States". Circulation, 139(12), 1563-1564. https://doi.org/10.1161/CIRCULATIONAHA.118.039290

Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States". / Siontis, Konstantinos C.; Zhang, Xiaosong; Schaubel, Douglas E. et al.
In: Circulation, Vol. 139, No. 12, 19.03.2019, p. 1563-1564.

Research output: Contribution to journal › Letter › peer-review

Siontis, KC, Zhang, X, Schaubel, DE, Yao, X , Noseworthy, PA, Shah, ND, Saran, R & Nallamothu, BK 2019, 'Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"', Circulation, vol. 139, no. 12, pp. 1563-1564. https://doi.org/10.1161/CIRCULATIONAHA.118.039290

@article{f18ebf74361d49179921b2441ab5697f,

title = "Response by Siontis et al to Letter Regarding Article, {"}Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States{"}",

author = "Siontis, {Konstantinos C.} and Xiaosong Zhang and Schaubel, {Douglas E.} and Xiaoxi Yao and Noseworthy, {Peter A.} and Shah, {Nilay D.} and Rajiv Saran and Nallamothu, {Brahmajee K.}",

year = "2019",

month = mar,

day = "19",

doi = "10.1161/CIRCULATIONAHA.118.039290",

language = "English (US)",

volume = "139",

pages = "1563--1564",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"

AU - Siontis, Konstantinos C.

AU - Zhang, Xiaosong

AU - Schaubel, Douglas E.

AU - Yao, Xiaoxi

AU - Noseworthy, Peter A.

AU - Shah, Nilay D.

AU - Saran, Rajiv

AU - Nallamothu, Brahmajee K.

PY - 2019/3/19

Y1 - 2019/3/19

UR - http://www.scopus.com/inward/record.url?scp=85063265956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063265956&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.118.039290

DO - 10.1161/CIRCULATIONAHA.118.039290

M3 - Letter

C2 - 30883218

AN - SCOPUS:85063265956

SN - 0009-7322

VL - 139

SP - 1563

EP - 1564

JO - Circulation

JF - Circulation

IS - 12

ER -

Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this